Displaying drugs 2651 - 2675 of 3222 in total
PF-03814735
PF-03814735 has been used in trials studying the treatment of Solid Tumors.
Investigational
Arginine glutamate
Investigational
Ethyl Oxo(Piperidin-1-Yl)Acetate
Experimental
[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,
Experimental
(Diaminomethyl-Methyl-Amino)-Acetic Acid
Experimental
RPR131247
Experimental
Glycocyamine
Experimental
(Carboxyhydroxyamino)Ethanoic Acid
Experimental
N-hexadecanoylglycine
Experimental
Cephalothin Group
Cephalothin group is a solid. This compound belongs to the 1,3-thiazines. These are organic compounds containing 1,3-thiazine, a six-member ring with a nitrogen and a sulfur atom in ring positions 1 and 3 respectively, as well as two double bonds. This substance is known to target beta-lactamase Toho-1 and D-alanyl-D-alanine...
Experimental
Cp-Coeleneterazine
Experimental
CHROMOPHORE (LYS-TYR-GLY)
Experimental
MB-07803
MB07803 is a second generation gluconeogenesis inhibitor for the treatment of type 2 diabetes. It is designed to block the metabolic pathway in the liver that is responsible for producing glucose.
Investigational
Faropenem medoxomil
Faropenem medoxomil is an ester prodrug derivative of the beta-lactam antibiotic faropenem. The prodrug form of faropenem offers dramatically improved oral bioavailability and leads to higher systemic concentrations of the drug. Faropenem medoxomil is a broad-spectrum antibiotic that is highly resistant to beta-lactamase degradation. It is being developed jointly by...
Investigational
Displaying drugs 2651 - 2675 of 3222 in total